How the Delta Variant Fight Will Unleash a Wave of Genomics Innovation

Here we go again… Just when we thought the pandemic was over and it would be just a matter of time before life returned to normal, the delta variant comes along. We’re now in the middle of a third wave of COVID-19. With the seven-day average of reported infections running at more than 100,000 as … Read More

Investing in the Most Innovative Companies During the Era of COVID…

The Centers for Disease Control and Prevention reports that more than 96 million people in the United States have been fully vaccinated against COVID-19 as of April 27. And the number of new cases in the U.S. is down significantly since January. That’s largely because of rapid medical innovation. As Alexander Green has mentioned before, … Read More

A Mega Trend Likely to Continue for Years to Come

We’re finally seeing the Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) vaccines in action. We’ve been hearing about these medicines and how they work in the lab. Drug trials showed that around 95% of vaccine patients were safe from COVID-19 infection before the shots rolled out to the public. But now, we’re finally getting reports … Read More